anim
human
subject
perform
group
sinc
chang
et
al
explor
would
like
investig
interact
os
select
singl
herb
wen
bing
formula
thu
eight
herb
name
radix
isatidi
chen
et
al
radix
et
rhizoma
glycyrrhiza
micha
et
al
sekineosajima
et
al
wolkerstorf
et
al
radix
scutellaria
xu
et
al
fructu
forsythia
li
et
al
flo
lonicera
japonica
lu
et
al
folium
mori
savov
et
al
herba
schizonepeta
et
al
fructu
arctii
hayashi
et
al
select
studi
base
flow
cariteria
commonli
use
tradit
wen
bing
formula
ii
efficaci
select
herb
china
pharmacopeaia
clearli
relat
antiinfluenza
effect
base
tcm
iii
select
herbstheir
herbal
compon
antivir
effect
influenza
viral
modern
pharmacolig
studi
addtion
ten
relev
marker
compon
eight
herb
also
select
help
understand
interact
os
herb
epigoitrin
radix
isatidi
glycyrrhiz
acid
liquirtin
radix
et
rhizoma
glycyrrhiza
baicalein
baicalein
wogonin
radix
scutellaria
phillyrin
fructu
forsythia
chlorogen
acid
flo
lonicera
japonica
rutin
folium
mori
arctiin
fructu
arctii
os
ethyl
ester
prodrug
oseltamivir
acid
osa
ro
potent
select
inhibitor
neuraminidas
glycoprotein
essenti
replic
influenza
b
virus
et
al
current
market
trade
name
tamiflu
roch
approv
treatment
influenza
prophylaxi
influenza
us
fda
outbreak
influenza
viru
subtyp
commonli
refer
swine
flu
caus
fatal
infect
death
countri
world
health
organ
recommend
tamiflu
earli
treatment
swine
flu
os
oral
well
absorb
metabol
osa
carboxylesteras
invivo
et
al
shi
et
al
without
interact
human
cytochrom
glucuronosyltransferas
et
al
osa
anion
prove
substrat
organ
anion
tublar
secret
transport
oat
renal
secret
deguchi
et
al
os
osa
substrat
p
glycoprotein
pgp
accordingli
low
level
pgp
activ
drugdrug
interact
pgp
may
lead
enhanc
brain
accumul
oseltamivir
may
turn
account
central
nervou
system
effect
oseltamivir
observ
patient
morimoto
et
al
recent
studi
suggest
oseltamivir
also
substrat
peptid
transport
intestin
absorpt
ogihara
et
al
os
limit
potenti
clinic
relev
pharmacokinet
interact
commonli
coadminist
drug
paracetamol
cimetidin
amoxicllin
aspirin
antacid
dutkowski
et
al
compar
drugdrug
interact
os
report
herbdrug
interact
even
fewer
effect
herbal
supplement
tradit
medicin
includ
extract
six
tradit
cree
botan
commerci
avail
echinacea
product
goldens
tradit
chines
medicin
invitro
activ
human
hepat
microsomalmedi
metabol
os
evalu
liu
et
al
find
suggest
potenti
health
herbal
supplement
use
patient
respons
pandem
reduc
efficaci
os
howev
potenti
clinic
signific
interact
studi
addit
limit
report
herbdrug
interact
os
pharmacokinet
level
found
potenti
interact
could
also
pharmacodynam
level
pomegran
polyphenol
extract
demonstr
invitro
inhibit
replic
human
influenza
ahong
kong
also
shown
synergist
effect
os
haidari
et
al
previou
find
chang
et
al
pharmacokinet
pharmacodynam
interact
os
anim
human
subject
suggest
coadministr
os
mgkg
bid
day
gkg
bid
day
human
equival
dose
rat
would
lead
significantli
enhanc
coadminstr
os
mg
bid
day
g
bid
day
healthi
male
subject
zuo
et
al
demonstr
similar
trend
reduct
plasma
concentr
osa
enhanc
antivir
activ
metabol
transport
os
could
significantli
inhibit
compon
dosedepend
manner
among
arctigenin
demonstr
strongest
inhibitor
well
strong
antivir
activ
ic
valu
identifi
invitro
plaqu
reduct
assay
although
absorpt
disposit
os
well
identifi
potenti
effect
herbsherb
compon
characterist
remain
investig
therefor
propos
establish
invitro
screen
platform
investig
potenti
herb
herbal
compon
may
pharmacokinet
pharmacodynam
interact
os
screen
platform
base
avail
knowledg
absorpt
disposit
antivir
activ
os
built
exist
model
invitro
enzymat
reaction
liver
microsom
invitro
transport
use
cell
line
overexpress
pgp
oat
invitro
plaquereduct
assay
raw
herb
name
radix
isatidi
radix
et
rhizoma
glycyrrhiza
radix
scutellaria
fructu
forsythia
flo
lonicera
japonica
folium
mori
herba
schizonepeta
fructu
arctii
purchas
hong
wang
herbal
drug
store
hong
kong
authent
compound
epigoitrin
glycyrrhiz
acid
liquirtin
baicalein
baicalin
wogonin
phillyrin
chlorogen
acid
rutin
arctiin
purchas
chengdu
must
biotechnolog
co
ltd
chengdu
china
content
authent
compound
studi
herb
determin
use
lcmsm
method
employ
agil
tripl
quadrupl
mass
spectromet
agil
technolog
coupl
electrospray
ioniz
esi
sourc
ms
paramet
separ
condit
optim
herb
shown
tabl
content
herb
determin
use
extern
calibr
method
triplic
sampl
prepar
herb
analyz
final
concentr
gram
herbal
extract
summar
tabl
commerci
avail
standard
purifi
radix
scutellaria
extract
rs
obtain
shanghai
usea
biotech
co
ltd
shanghai
china
batch
number
qualiti
control
standard
number
content
ww
rs
respect
quantifi
lcm
ms
method
oseltamivir
os
oseltamivir
acid
osa
puriti
kindli
provid
roch
compani
st
loui
mo
usa
albuterol
intern
standard
purchas
sigmaaldrich
chem
hygromycin
b
glycylsarcosin
glysar
thiazolyl
blue
tetrazolium
bromid
mtt
purchas
sigmaaldrich
chem
co
milwauke
wi
usa
cell
cultur
dulbecco
modifi
eagl
medium
trypsinedta
fetal
bovin
serum
penicillinstreptomycin
hank
balanc
salt
solut
hbss
sodium
butyr
nonessenti
amino
acid
purchas
gibco
brl
co
ltd
carlsbad
ca
usa
lifer
technolog
grand
island
ny
usa
sixwel
plate
transwel
insert
mm
id
cm
pore
size
polycarbon
filter
purchas
corn
costar
corpor
corn
ny
usa
biocoat
polydlysin
plate
purchas
becton
dickinson
franklin
lake
nj
usa
phosphat
buffer
salin
pb
nadp
rat
liver
microsom
rlm
human
recombin
carboxylesteras
dehydrogenas
mgcl
purchas
sigma
st
loui
mo
usa
rat
blank
plasma
freshli
prepar
sacrif
spraguedawley
sd
rat
acetonitril
methanol
labscan
asia
bangkok
thailand
hplc
grade
reagent
bdh
laboratori
dorset
england
analyt
grade
distil
deioniz
water
prepar
millipor
water
purif
system
millipor
milford
usa
mdckwt
cell
gener
provid
prof
p
borst
netherland
cancer
institut
cell
cultur
mdckwt
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
nonessenti
amino
acid
atmospher
co
rel
humid
mdck
cell
subcultur
trypsinedta
min
follow
plate
onto
sixwel
transwel
insert
coat
collagen
densiti
cellswel
transepitheli
electr
resist
teer
valu
measur
monitor
integr
mdck
cell
monolay
mdck
monolay
teer
could
employ
transport
studi
cell
purchas
american
type
cultur
collect
cell
cultur
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
nonessenti
amino
acid
uml
penicillin
uml
streptomycin
atmospher
co
rel
humid
cell
subcultur
trypsin
trypsinedta
min
seed
onto
sixwel
plate
densiti
cellscm
around
day
follow
uptak
studi
empti
vector
mock
transfect
human
organ
anion
transport
transfect
cell
gener
provid
prof
dafang
zhong
shanghai
institut
materia
medica
cell
cultur
cultur
flask
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
nonessenti
amino
acid
uml
penicillin
uml
streptomycin
hygromycin
b
atmospher
co
rel
humid
cell
seed
onto
biocoat
polydlysineco
plate
densiti
cellswel
ml
per
well
induc
express
transport
medium
plate
replac
fresh
cultur
medium
contain
mm
sodium
butyr
h
uptak
studi
screen
inhibit
os
hydrolysi
plasma
liver
select
herbsherb
compon
metabol
inhibit
os
hydrolysi
rat
plasma
herbherb
compon
dilut
rat
plasma
spike
herb
herbal
compon
mgml
mgml
dissolv
dmso
control
group
spike
dmso
reaction
mixtur
preincub
min
water
bash
os
ad
initi
reaction
final
mixtur
incub
min
termin
ad
icecold
acetonitril
intern
standard
ngml
albuterol
water
vertex
centrifug
rpm
min
supernat
inject
lcmsm
analysi
thaw
rat
liver
microsom
rlm
slowli
ice
adjust
concentr
mgml
incub
system
compos
mm
pb
os
herb
compon
mgml
rlm
preincub
mixtur
water
bath
min
initi
reaction
addit
mm
nadph
regener
system
nadp
dehydrogenas
incub
min
gentl
agit
termin
reaction
addit
icecold
acetonitril
h
vortex
sampl
centrifug
rpm
min
pipett
supernat
intern
standard
ngml
albuterol
water
water
vortex
centrifug
supernat
inject
lcmsm
analysi
thaw
slowli
ice
dilut
mm
pb
ph
preincub
water
bath
hydrolysi
reaction
initi
addit
os
herbal
compon
final
concentr
min
reaction
termin
ad
mgml
dichlorvo
mix
pb
vortex
sampl
centrifug
rpm
min
pipett
supernat
intern
standard
ngml
albuterol
water
water
vortex
centrifug
supernat
inject
lcmsm
analysi
cytotox
os
combin
select
herbsherb
compon
interfer
growth
mdckwt
cell
determin
mtt
assay
cell
seed
onto
plate
densiti
cellswel
dmem
cultur
medium
cultur
atmospher
co
rel
humid
h
subsequ
cultur
medium
replac
os
without
herbsherb
compon
hbss
differ
studi
concentr
concentr
shown
follow
os
herbal
extract
rang
mgml
mgml
herbal
compon
rang
ml
blank
hbss
ph
use
neg
control
incub
plate
h
mgml
mtt
solut
hbss
ad
well
follow
continu
incub
anoth
h
solut
well
remov
care
follow
dissolv
remain
formazan
crystal
dmso
absorb
subsequ
measur
micropl
reader
molecular
devic
downingtown
pa
usa
nm
cytotox
os
without
herbsherb
compon
calcul
percentag
absorb
rel
neg
control
identifi
potenti
modif
pgp
mediat
transport
os
herbsherb
compon
b
transport
studi
os
without
herbsherb
compon
carri
mdckwt
cell
line
cell
rins
twice
equilibr
hbss
experi
test
solut
os
dissolv
hbss
without
herbsherb
compon
load
apic
side
chamber
ap
ml
volum
solut
collect
basolater
side
bl
ml
volum
min
min
min
min
follow
replac
equal
volum
blank
hbss
receiv
chamber
final
subject
analysi
os
lcmsm
cell
use
screen
herbsherb
compon
determin
effect
uptak
os
via
cell
grown
plate
day
rins
hbss
contain
mm
glysar
twice
preincub
min
uptak
studi
preincub
test
solut
os
dissolv
hbss
without
herbsherb
compon
ad
initi
uptak
uptak
os
increas
linearli
min
thu
cell
incub
min
wash
time
ml
icecold
blank
hbss
termin
uptak
os
cell
lyse
multigel
method
content
os
cell
analyz
lcmsm
cell
use
illustr
effect
herbsherb
compon
modif
os
via
cell
wash
twice
hbss
day
preincub
min
experi
initi
addit
hbss
contain
os
without
herbsherb
compon
termin
remov
solut
wash
time
care
icecold
hbss
subsequ
cell
lyse
multigel
method
supernat
process
inject
lcmsm
analysi
os
pharmacokinet
pharmacodynam
interact
os
radix
scutellaria
rs
select
invitro
screen
test
anim
group
treatment
experi
carri
approv
anim
ethic
committe
chines
univers
hong
kong
ref
male
spraguedawley
sd
rat
g
use
experi
provid
laboratori
anim
servic
center
chines
univers
hong
kong
hong
kong
sar
peopl
republ
china
solut
oseltamivir
os
mgml
freshli
prepar
experi
dissolv
os
deioniz
water
rs
extract
prepar
suspens
low
dose
mgg
high
dose
mgg
water
contain
ww
total
rat
randomli
divid
group
rat
group
receiv
variou
oral
drug
treatment
day
day
rat
receiv
dose
mgkg
os
rat
given
water
time
day
dose
administ
rat
water
mgkg
rs
mgkg
rs
respect
day
h
receiv
jugular
vein
cannul
surgeri
perform
rat
light
anesthesia
surgeri
rat
place
individu
metabol
cage
allow
recov
overnight
fast
free
access
water
dose
day
blood
sampl
ml
obtain
via
cathet
min
post
dose
blood
sampl
ml
normal
salin
contain
unitsml
heparin
immedi
inject
cathet
flush
cathet
urin
sampl
collect
h
postdos
combin
volum
water
use
rins
metabol
cage
collect
urin
sampl
store
analysi
min
follow
dose
day
rat
anesthet
ml
blood
collect
rat
inferior
vena
determin
antivir
activ
blood
sampl
collect
group
treatment
serv
control
rat
plasma
dilut
urin
sampl
purifi
water
oasi
mcx
extract
cartridg
cc
mg
per
follow
procedur
equilibr
cartridg
ml
methanol
ml
h
contain
formic
acid
fa
sequenc
load
sampl
mixtur
contain
rat
plasmadilut
urin
standard
solut
fah
ngml
caffein
h
intern
standard
onto
cartridg
wash
ml
water
appli
ammonium
hydroxid
methanol
elut
solvent
let
zhang
et
al
journal
ethnopharmacolog
flow
graviti
switch
vacuum
pump
evapor
eluent
dryness
reduc
pressur
reconstitut
mobil
phase
methanol
fa
h
analyz
follow
lcmsm
method
agil
tripl
quadrupl
mass
spectromet
agil
technolog
coupl
electrospray
ioniz
esi
sourc
employ
detect
os
osa
abovement
biosampl
ms
paramet
separ
condit
optim
kind
biosampl
gener
nitrogen
use
desolv
lmin
nebul
ga
psi
sourc
paramet
esi
temperatur
sourc
voltag
v
delta
emv
v
chromatograph
separ
achiev
sunfir
c
column
mm
id
equip
guard
filter
mobil
phase
consist
eluent
formic
acid
water
b
acetonitril
aliquot
sampl
inject
elut
column
flow
rate
mlmin
isocrat
elut
program
eluent
b
temperatur
autosampl
column
set
ambient
respect
mrm
scan
mdck
cell
line
grown
dmem
high
glucos
pyruv
supplement
fetal
bovin
serum
mm
lglutamin
thermo
fisher
scientif
massachusett
usa
co
batch
clinic
isol
collect
princ
wale
hospit
evalu
replic
plaqu
format
mdck
cell
virus
propag
mdck
cell
mainten
medium
dmem
high
glucos
pyruv
supplement
fetal
bovin
serum
mm
lglutamin
tpcktreat
trypsin
replic
abil
assess
immunefluoresc
stain
cell
cultur
harvest
use
influenza
aspecif
antibodi
viru
isol
show
satisfactori
growth
abil
select
assess
plaqu
form
abil
method
detail
quantifi
stock
appropri
isol
known
number
plaqu
form
unit
pfu
kept
use
plaqu
reduct
assay
mdck
cell
seed
cell
per
well
plate
incub
overnight
reach
confluenc
viru
stock
concentr
pfuml
pfuml
use
prepar
mixtur
contain
virus
rat
plasma
sampl
differ
optim
number
pfu
use
isol
gener
differ
size
plaqu
mixtur
virus
test
compound
incub
co
h
gentl
shake
sever
time
allow
even
mix
cell
wash
dmem
contain
tpcktreat
trypsin
incub
ml
mediumagar
overlay
h
agar
overlay
contain
equal
volum
melt
agaros
mdck
mainten
medium
kept
ad
well
h
incub
cell
monolay
fix
formaldehyd
overnight
room
temperatur
stain
crystal
violet
min
room
temperatur
number
plaqu
form
examin
nake
eye
assist
magnifi
glass
necessari
data
analys
effect
herbherb
compon
hydrolysi
transport
uptak
os
inhibit
os
hydrolysi
osa
format
rate
calcul
molar
amount
osa
divid
reaction
time
volum
rat
plasma
protein
amount
rlm
pgp
transport
studi
appar
permeabl
coeffici
p
app
obtain
describ
li
et
al
estim
potenti
modif
os
herbsherb
compon
uptak
studi
cell
uptak
amount
os
obtain
compar
group
absenc
presenc
herbsherb
compon
select
herb
verif
potenti
herbdrug
interact
hdi
rat
comprehens
compar
influenti
herbsherb
compon
inhibit
os
hydrolysi
transportuptak
os
result
experi
express
fold
chang
fc
follow
equat
result
os
plu
herbherb
compon
experi
c
os
os
plu
inhibitor
cell
studi
experi
fc
valu
experi
would
convert
zscore
follow
equat
x
mean
fc
valu
standard
deviat
fc
valu
one
experi
nonlinear
mixedeffect
model
perform
nonmem
version
icon
develop
solut
ellicott
citi
maryland
usa
perlspeaksnonmem
version
uppsala
univers
uppsala
sweden
structur
model
build
perform
advan
first
order
condit
method
interact
foce
variancecovari
matrix
calcul
use
default
method
estim
rel
standard
error
rse
paramet
final
model
establish
stepwis
manner
per
follow
criteria
minimum
object
function
valu
ofv
success
minim
covari
calcul
rse
accept
addit
paramet
drop
ofv
p
shrinkag
accept
addit
interindividu
variabl
iiv
one
paramet
model
also
visual
qualifi
base
goodnessoffit
plasma
concentrationtim
profil
accumul
urin
amount
os
osa
individu
popul
level
visual
predict
check
vpc
bootstrap
procedur
n
use
intern
valid
tool
ensur
rugged
predict
final
model
bootstrap
estim
median
percentil
obtain
repres
nonparametr
confid
interv
ci
inhibit
effect
eight
herb
extract
ten
marker
compon
hydrolysi
os
evalu
rat
plasma
rlm
incub
os
presenc
absenc
studi
herbherb
compon
incub
system
rat
plasma
contain
os
rat
plasma
sinc
superfast
reaction
rate
rat
plasma
result
discrimin
nearli
studi
herbherb
compon
result
demonstr
fig
format
rate
osa
could
significantli
suppress
herbherb
compon
among
select
herb
fructu
forsythia
fructu
arctii
almost
complet
inhibit
hydrolysi
os
os
remain
min
incub
herbal
compon
marker
compound
radix
scutellaria
could
inhibit
os
hydrolysi
result
rlm
show
similar
trend
ten
marker
compon
fig
zhang
et
al
journal
ethnopharmacolog
significantli
suppress
os
hydrolysi
suggest
hydrolysi
os
rlm
mainli
mediat
analogu
show
signific
cytotox
concentr
mgml
addit
correspond
ten
test
herbal
compon
show
signific
cytotox
mdckwt
cell
concentr
viabil
cell
presenc
oseltamivir
herbsherb
compon
studi
highest
concentr
maximum
concentr
herb
herbal
compon
transport
uptak
studi
therefor
set
mgml
respect
mdckwt
cell
shown
fig
p
app
valu
os
significantli
increas
coincub
baicalein
radix
et
rhizoma
glycyrrhiza
glycyrrhiz
acid
suggest
could
inhibit
efflux
effect
pgp
thu
promot
absorpt
os
sinc
transfect
cell
avail
use
glysar
inhibit
check
coincub
herbsherb
compon
could
decreas
uptak
os
inhibit
result
shown
fig
ad
inhibitor
uptak
amount
os
significantli
lower
howev
coincub
herb
herbal
compon
signific
reduct
os
uptak
observ
contrari
herb
herbal
compon
could
increas
uptak
os
cell
seem
uptak
transport
domin
way
absorpt
os
increas
uptak
may
due
inhibit
pgp
shown
fig
differ
observ
cell
updat
os
suggest
os
substrat
transport
accordingli
signific
increas
os
uptak
also
observ
incub
herb
herbal
compon
invitro
experi
suggest
potenti
hdi
os
antiinfluenza
herbsherb
compon
absorpt
metabol
sinc
test
hdi
rat
model
expens
timeconsum
prefer
select
one
herb
possibl
hdi
perform
invivo
experi
make
compar
result
six
invitro
experi
origin
valu
convert
foldchang
fc
control
group
herbherb
compon
interfer
fc
valu
experi
convert
zscore
use
ztransform
ztransform
result
differ
experi
would
compar
sinc
mean
standard
deviat
zscore
alway
zero
one
respect
zscore
experi
given
fig
sum
valu
absolut
zscore
herbherb
compon
given
top
fig
right
sampl
result
base
sum
valu
absolut
zscore
radix
scutellaria
highest
score
among
studi
herb
select
invivo
experi
per
invitro
screen
cell
enzym
found
radix
scutellaria
marker
compon
clear
hint
interact
os
absorpt
transport
metabol
process
thu
standard
herbal
extract
radix
scutellaria
rs
util
perform
herbdrug
interact
studi
os
rat
day
administr
propos
dosag
describ
section
plasmaconcentr
profil
os
osa
group
os
w
fig
right
correspond
accumul
amount
urin
obtain
data
analyz
use
noncompartment
analysi
tabl
result
suggest
coadministr
rs
could
significantli
increas
system
exposur
os
decreas
osa
fig
verifi
lower
osao
ratio
rat
urin
sampl
coadministr
rs
fig
better
understand
interact
mechan
os
rs
absorpt
metabol
process
popul
pharmacokinet
poppk
model
develop
use
plasma
urin
pk
data
group
os
w
shown
fig
left
final
model
four
compartment
pk
model
two
compart
os
osa
distribut
anoth
two
repres
reservoir
os
osa
urin
two
absorpt
compart
one
directli
absorb
amount
os
one
firstpass
elimin
amount
os
os
absorb
deposit
compart
central
compart
via
firstord
process
k
disposit
os
osa
could
describ
onecompart
model
report
volum
distribut
os
osa
rat
lkg
respect
ratio
equal
divid
thu
final
model
distribut
volum
os
v
osa
assum
v
format
osa
os
either
firstpass
metabol
os
central
compart
via
cl
determin
coadministr
rs
could
lead
differ
structur
paramet
k
cl
v
fp
fig
heat
map
ztransform
foldchang
result
zscore
invitro
inhibit
os
hydrolysi
rat
plasma
rp
rat
liver
microsom
rlm
human
recombin
carboxylesteras
modif
pgp
mediat
transport
herb
herbal
compon
zhang
et
al
journal
ethnopharmacolog
bio
k
e
os
k
e
osa
model
develop
process
model
ident
differ
structur
paramet
among
three
group
tri
compar
drop
ofv
bigger
p
structur
paramet
thought
significantli
differ
coadministr
rs
tabl
found
coadministr
rs
effect
absorpt
rate
constant
k
metabol
clearanc
cl
os
would
decreas
v
increas
remain
structur
paramet
fp
bio
k
e
os
k
e
osa
interindividu
variabl
iiv
success
estim
paramet
cl
v
k
howev
structur
paramet
iiv
tend
zero
shrinkag
close
error
model
addit
proport
error
ad
observ
valu
plasma
urin
respect
due
rse
addit
error
high
addit
error
fix
zero
proport
error
includ
final
model
also
tri
use
one
proport
error
paramet
plasma
urin
data
led
increas
ofv
goodnessoffit
plot
show
good
agreement
predict
observ
concentrationsamount
appar
bia
residu
fig
vpc
result
final
model
present
fig
overal
percentil
observ
concentr
within
predict
confid
interv
ci
percentil
suggest
accur
model
fit
across
differ
interfer
group
bootstrap
result
median
paramet
estim
ci
like
estim
origin
dataset
indic
final
model
provid
good
precis
paramet
estim
tabl
observ
microscop
morpholog
chang
mdck
cell
incub
serial
dilut
dilut
rat
plasma
h
show
maximum
concentr
plasma
prepar
could
use
plaqu
reduct
assay
plasma
dilut
use
plaqu
reduct
assay
viru
plaqu
reduct
result
group
shown
tabl
result
mean
valu
rat
plasma
sampl
test
triplic
plaqu
obtain
herb
oseltamivir
administr
use
refer
herb
group
show
signific
reduct
viru
plaqu
either
signific
reduct
number
viru
plaqu
observ
oseltamivir
treat
group
coadministr
onetwo
time
hed
rs
extract
os
increas
total
antiviru
effect
current
studi
screen
platform
base
microsom
enzym
cell
influenza
virus
first
time
develop
util
screen
potenti
interact
os
antiinfluenza
herbherb
compon
plenti
meaning
inform
obtain
differ
level
vari
degre
metabol
inhibit
studi
perform
rat
plasma
suggest
herbal
extract
herbal
compon
ml
could
inhibit
hydrolysi
os
rat
plasma
inhibit
rate
vari
herbsherb
compon
unexpectedli
notic
differ
inhibit
trend
microsom
purifi
enzym
incub
studi
show
strongest
fig
structur
popul
pharmacokinet
model
left
see
tabl
full
name
paramet
mean
plasma
concentr
versu
time
profil
right
oral
administr
os
mgkg
absenc
os
w
presenc
mgkg
mg
kg
radix
scutellaria
rat
n
per
group
concentr
given
mean
sd
tabl
paramet
estim
final
model
rat
oral
administr
mgkg
os
alon
os
w
coadministr
mgkg
rs
os
mgkg
rs
os
estim
inhibit
os
hydrolysi
rat
plasma
inhibit
microsom
system
among
herbal
compon
herbal
compon
strongest
inhibitor
os
hydrolysi
microsom
rat
plasma
rank
behind
composit
enzym
rat
plasma
much
complex
microsom
major
esteras
plasma
butyrylcholinesteras
bche
paraoxonas
pon
carboxylesteras
ce
bahar
et
al
abund
plasma
protein
albumin
occasion
show
hydrolyz
activ
esterifi
compound
hydrolyz
major
plasma
protein
via
differ
catalyt
mechan
hydrolas
activ
rat
plasma
may
origin
one
kind
enzym
inhibit
activ
herbal
compon
kind
hydrolysi
enzym
differ
work
perform
clarifi
inhibit
mechan
herbal
compon
sinc
data
six
invitro
experi
differ
unit
intens
rang
compar
directli
current
propos
method
first
convert
raw
valu
experi
fold
chang
fc
control
group
normal
fc
valu
experi
ztransform
make
result
differ
natur
compar
experi
fold
chang
measur
describ
much
quantiti
chang
go
initi
control
final
valu
often
use
analysi
gene
express
data
microarray
rnaseq
experi
measur
chang
express
level
gene
tusher
et
al
experi
fc
could
consid
contribut
herb
herbal
compon
experi
fc
far
one
bigger
less
like
studi
herbsherb
compon
hdi
os
howev
fc
still
could
compar
experi
due
vari
fc
rang
experi
inspir
multivari
statist
method
varmuza
filzmos
chose
ztransform
common
normal
method
normal
fc
valu
experi
make
distribut
n
normal
absolut
zscore
herbherb
compon
effect
os
would
proport
level
hdi
relev
os
thu
sum
absolut
zscore
herbherb
compon
six
invitro
experi
would
indic
hdi
potenti
base
invitro
screen
result
rs
extract
coadministr
os
five
day
kind
combin
indic
coadministr
rs
extract
os
could
significantli
increas
system
exposur
os
decreas
system
exposur
osa
consist
observ
coadministr
herbal
formula
contain
rs
os
zuo
et
al
plasma
sampl
evalu
influenza
viru
herbonli
group
show
viru
plaqu
reduct
effect
oseltamivir
group
could
significantli
reduc
number
plaqu
viru
addit
effect
observ
coadministr
os
rs
extract
reason
interact
os
rs
observ
pharmacokinet
pharmacodynam
could
due
differ
timepoint
current
pk
pd
evalu
pk
studi
plasma
concentr
data
timepoint
use
one
timepoint
h
oseltamivir
administr
use
pd
studi
accord
pk
profil
concentr
osa
around
h
approxim
calcul
use
mean
valu
h
h
calcul
osa
concentr
h
ngml
respect
show
signific
differ
two
group
calcul
osa
concentr
three
group
perform
twotail
ttest
sinc
differ
osa
concentr
oseltamivir
treat
group
antiviru
effect
mainli
origin
osa
could
deduc
antiviru
effect
differ
observ
three
group
develop
model
simultan
fit
pk
accumul
urin
concentr
data
group
provid
sever
mechanist
quantit
insight
interact
os
rs
follow
pk
os
exhibit
flipflop
kinet
oral
administr
evidenc
much
slower
k
absorpt
rate
constant
k
e
elimin
rate
constant
shown
tabl
thu
slow
termin
phase
os
fig
right
would
repres
absorpt
rather
elimin
os
therefor
observ
elimin
phase
os
suggest
elimin
rate
os
fast
captur
coadministr
rs
bio
absorb
fraction
fp
fraction
escap
firstpass
metabol
success
estim
urin
pk
data
intraven
pk
os
os
coadministr
group
avail
assumpt
use
urin
pk
estim
bio
major
absorb
os
would
collect
urin
form
os
metabolit
osa
alreadi
verifi
rat
human
studi
et
al
estim
bio
os
administr
os
slightli
lower
report
oral
bioavail
rat
singl
dose
mgkg
os
li
et
al
moreov
current
model
method
integr
plasma
urin
pk
advantag
use
less
rat
iv
group
need
shown
tabl
coadministr
rs
bio
os
increas
without
chang
absorpt
rate
k
suggest
rs
would
increas
absorb
fraction
os
inhibit
pgp
efflux
evidenc
section
rather
chang
permeabl
although
rs
could
also
increas
fp
inhibit
hydrolysi
os
absorpt
process
inhibit
system
hydrolysi
os
signific
unchang
cl
due
rel
small
amount
absorb
rs
compon
ubiquit
distribut
rat
plasma
furihata
et
al
develop
poppk
model
let
us
interpret
contradictori
phenomena
coadministr
rs
would
increas
elimin
rate
system
exposur
auc
os
rat
mainli
caus
decreas
volum
distribut
v
os
chang
v
may
need
verif
collect
intraven
data
rat
poppk
model
could
separ
estim
metabol
clearanc
cl
renal
clearanc
k
e
os
v
os
total
bodi
clearanc
os
cl
k
e
os
v
estim
model
lhkg
compar
report
clearanc
lhkg
intraven
inject
mgkg
os
rat
li
et
al
coadministr
rs
renal
clearanc
rather
metabol
clearanc
os
increas
lhkg
suggest
rs
could
acceler
elimin
os
bodi
warrant
invivo
verif
intraven
pharmacokinet
os
five
day
oral
coadministr
os
rs
platform
includ
sixdimens
invitro
screen
invivo
pharmacokinet
rat
exvivo
pharmacodynam
evalu
develop
success
appli
find
rs
potenti
herb
would
influenc
coadministr
os
rat
work
set
good
exampl
demonstr
feasibl
advantag
use
multidisciplinari
techniqu
includ
experiment
scienc
informat
pharmacometr
investig
herbdrug
interact
potenti
herbdrug
interact
hdi
os
herbherb
compon
observ
current
project
serv
good
platform
identifi
potenti
interact
herb
relat
mechan
futur
clinic
monitor
os
integr
medicin
practic
human
subject
sixdimens
invitro
screen
identifi
rs
herb
hdi
potenti
os
coadminist
rs
could
inhibit
os
hydrolysi
absorpt
increas
absorb
fraction
os
lead
increas
ratio
os
concentr
versu
osa
rat
plasma
urin
never
less
antiviru
effect
os
influenc
coadminist
rs
